These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 8599089

  • 1. The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.
    Wang T, Danielson PD, Li BY, Shah PC, Kim SD, Donahoe PK.
    Science; 1996 Feb 23; 271(5252):1120-2. PubMed ID: 8599089
    [Abstract] [Full Text] [Related]

  • 2. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
    Ebner R, Chen RH, Lawler S, Zioncheck T, Derynck R.
    Science; 1993 Nov 05; 262(5135):900-2. PubMed ID: 8235612
    [Abstract] [Full Text] [Related]

  • 3. Characterization of type I receptors for transforming growth factor-beta and activin.
    ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin CH.
    Science; 1994 Apr 01; 264(5155):101-4. PubMed ID: 8140412
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J.
    Mol Cell Biol; 1994 Jun 01; 14(6):3810-21. PubMed ID: 8196624
    [Abstract] [Full Text] [Related]

  • 7. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.
    Lux A, Attisano L, Marchuk DA.
    J Biol Chem; 1999 Apr 09; 274(15):9984-92. PubMed ID: 10187774
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structural and functional evidence for a singular repertoire of BMP receptor signal transducing proteins in the lophotrochozoan Crassostrea gigas suggests a shared ancestral BMP/activin pathway.
    Herpin A, Lelong C, Becker T, Rosa F, Favrel P, Cunningham C.
    FEBS J; 2005 Jul 09; 272(13):3424-40. PubMed ID: 15978047
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P.
    Int Immunol; 2003 Dec 09; 15(12):1401-14. PubMed ID: 14645149
    [Abstract] [Full Text] [Related]

  • 12. Interaction of the transforming growth factor-beta type I receptor with farnesyl-protein transferase-alpha.
    Kawabata M, Imamura T, Miyazono K, Engel ME, Moses HL.
    J Biol Chem; 1995 Dec 15; 270(50):29628-31. PubMed ID: 8530343
    [Abstract] [Full Text] [Related]

  • 13. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
    Alexander JM, Bikkal HA, Zervas NT, Laws ER, Klibanski A.
    J Clin Endocrinol Metab; 1996 Feb 15; 81(2):783-90. PubMed ID: 8636304
    [Abstract] [Full Text] [Related]

  • 14. Interaction of transforming growth factor-beta receptor I with farnesyl-protein transferase-alpha in yeast and mammalian cells.
    Ventura F, Liu F, Doody J, Massagué J.
    J Biol Chem; 1996 Jun 14; 271(24):13931-4. PubMed ID: 8663177
    [Abstract] [Full Text] [Related]

  • 15. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.
    Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK.
    Cell; 1996 Aug 09; 86(3):435-44. PubMed ID: 8756725
    [Abstract] [Full Text] [Related]

  • 16. The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm.
    Bhushan A, Lin HY, Lodish HF, Kintner CR.
    Mol Cell Biol; 1994 Jun 09; 14(6):4280-5. PubMed ID: 8196664
    [Abstract] [Full Text] [Related]

  • 17. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
    Stockwell BR, Schreiber SL.
    Curr Biol; 1998 Jun 18; 8(13):761-70. PubMed ID: 9651680
    [Abstract] [Full Text] [Related]

  • 18. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
    Franzén A, Piek E, Westermark B, ten Dijke P, Heldin NE.
    Endocrinology; 1999 Sep 18; 140(9):4300-10. PubMed ID: 10465304
    [Abstract] [Full Text] [Related]

  • 19. A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.
    Muramatsu M, Yan J, Eto K, Tomoda T, Yamada R, Arai K.
    Mol Biol Cell; 1997 Mar 18; 8(3):469-80. PubMed ID: 9188099
    [Abstract] [Full Text] [Related]

  • 20. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.
    Wieser R, Wrana JL, Massagué J.
    EMBO J; 1995 May 15; 14(10):2199-208. PubMed ID: 7774578
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.